Publications by authors named "David Boltz"

Claim this Profile
I
Intranasal M2SR and BM2SR Vaccine Viruses Do Not Shed or Transmit in Ferrets.
Yasuko Hatta, Lindsay Hill-Batorski, Michael J Moser, David Marshall, David A Boltz

Vaccines (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting Efficacy of a Purified Inactivated Zika Virus Vaccine in Flavivirus-Naïve Humans Using an Immunological Correlate of Protection in Non-Human Primates.
Camilo J Acosta, Francesco Nordio, David A Boltz, Whitney R Baldwin, Greg Hather

Microorganisms· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enisamium Inhibits SARS-CoV-2 RNA Synthesis.
Stefano Elli, Denisa Bojkova, Marco Bechtel, Thomas Vial, David Boltz

Biomedicines· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy.
Ying Wang, Chen Yang, Yutong Song, J Robert Coleman, Marcin Stawowczyk, David Boltz

Proc Natl Acad Sci U S A· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enisamium Reduces Influenza Virus Shedding and Improves Patient Recovery by Inhibiting Viral RNA Polymerase Activity.
Aartjan J W Te Velthuis, Tatiana G Zubkova, Megan Shaw, Andrew Mehle, David Boltz

Antimicrob Agents Chemother· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trial.
Olha Holubovska, Denisa Bojkova, Stefano Elli, Marco Bechtel, David Boltz

medRxiv· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live-attenuated H1N1 influenza vaccine candidate displays potent efficacy in mice and ferrets.
Charles B Stauft, Chen Yang, J Robert Coleman, David Boltz, Chiahsuan Chin

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of enisamium, an isonicotinic acid derivative, against influenza viruses in differentiated normal human bronchial epithelial cells.
David Boltz, Xinjian Peng, Miguel Muzzio, Pradyot Dash, Paul G Thomas

Antivir Chem Chemother· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel influenza vaccine M2SR protects against drifted H1N1 and H3N2 influenza virus challenge in ferrets with pre-existing immunity.
Yasuko Hatta, David Boltz, Sally Sarawar, Yoshihiro Kawaoka, Gabriele Neumann

Vaccine· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
Yasuko Hatta, David Boltz, Sally Sarawar, Yoshihiro Kawaoka, Gabriele Neumann

Vaccine· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of DNA aptamers that bind to influenza A viruses with high affinity and broad subtype specificity.
Ikuo Shiratori, Joe Akitomi, David A Boltz, Katsunori Horii, Makio Furuichi

Biochem Biophys Res Commun· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination against influenza with recombinant hemagglutinin expressed by Schizochytrium sp. confers protective immunity.
Anne-Cécile V Bayne, David Boltz, Carole Owen, Yelena Betz, Goncalo Maia

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No evidence of a link between influenza vaccines and Guillain-Barre syndrome-associated antiganglioside antibodies.
David J Wang, David A Boltz, Janet McElhaney, Jonathan A McCullers, Richard J Webby

Influenza Other Respir Viruses· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.
Haeman Jang, David Boltz, Jennifer McClaren, Amar K Pani, Michelle Smeyne

J Neurosci· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis.
Susu Duan, David A Boltz, Jiang Li, Christine M Oshansky, Henju Marjuki

Antimicrob Agents Chemother· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets.
Susu Duan, David A Boltz, Patrick Seiler, Jiang Li, Karoline Bragstad

Influenza Other Respir Viruses· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drugs in development for influenza.
David A Boltz, Jerry R Aldridge, Robert G Webster, Elena A Govorkova

Drugs· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oseltamivir-resistant pandemic H1N1/2009 influenza virus possesses lower transmissibility and fitness in ferrets.
Susu Duan, David A Boltz, Patrick Seiler, Jiang Li, Karoline Bragstad

PLoS Pathog· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.
David A Boltz, Bounlom Douangngeun, Phouvong Phommachanh, Settha Sinthasak, Ricarda Mondry

J Gen Virol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration.
Haeman Jang, David Boltz, Katharine Sturm-Ramirez, Kennie R Shepherd, Yun Jiao

Proc Natl Acad Sci U S A· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral parkinsonism.
Haeman Jang, David A Boltz, Robert G Webster, Richard Jay Smeyne

Biochim Biophys Acta· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Field assessment of an H5N1 inactivated vaccine in chickens and ducks in Lao PDR.
David A Boltz, Bounlom Douangngeun, Settha Sinthasak, Phouvong Phommachanh, Phetlamphone Midouangchanh

Arch Virol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection.
Jerry R Aldridge, Carson E Moseley, David A Boltz, Nicholas J Negovetich, Cory Reynolds

Proc Natl Acad Sci U S A· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread.
Hui-Ling Yen, Jerry R Aldridge, Adrianus C M Boon, Natalia A Ilyushina, Rachelle Salomon, David A Boltz

Proc Natl Acad Sci U S A· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice.
David A Boltz, Natalia A Ilyushina, C Shane Arnold, Y Sudhakar Babu, Robert G Webster

Antiviral Res· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis